Authors | Study | N. PTS | Treatment | PFS (months) | PFS 6Â % | OS (months) |
---|---|---|---|---|---|---|
Van Den Bent et al. [15] | Phase II rand | 108 | BCNU or TMZ vs Erlotinib | 2.4 | 24.1 | 7.3 |
54 | 1.8 | 11.4 | 7.7 | |||
Brandes et al. [33] | Phase II | 40 | BCNU | NA | 17.5 | 7.5 |
Addeo et al. [18] | Phase II | 40 | Fotemustine | 6.7 | 61 | 11.1 |
Brada et al. [14] | Phase II | 126 | TMZ | 2.1 | 18 | 5.4 |
Wich et al. [29] | Phase II | 64 | TMZ 1wk on/1 wk off | 5.5 | 43.8 | NA |
Brada et al. [21] | Phase II rand | 87 | TMZ 5Â days | 5 | NA | 8.5 |
81 | TMZ 21Â days | 4.2 | 6.6 | |||
162 | PCV | 3.6 | 6.7 |